BIOCRYL sutures are indicated for general soft tissue approximation and/or ligation, including use in ophthalmic procedures. The safety and efficacy of Biocryl sutures in cardiovascular and neural tissues have not yet been established.
High tensile strength.
Extreme handling and easy knot execution.
Excellent knot hold security.
Excellent glide through tissue.
Predictable absorption profile.
Type
Braided and coated absorbable synthetic suture.
Molecule
Copolymer of 90% glycolic acid and 10% lactic acid (Polyglactin 910).
Tensile strength
The BIOCRYL suture, two weeks after implantation, maintains approximately 75% of its breaking strength, approximately 50% after three weeks. After four weeks, the breaking strength for USP 4/0 sutures is approximately 30% of its initial strength, for USP 2/0 it is less than 25%.
Absorption
Occurs via hydrolysis and is complete in approximately 56 to 70 days.